PR

Pavankumar Reddy Jalla

Active Director Director DIN 09659080
DIN 09659080 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pavankumar Reddy Jalla

Data last updated:

Pavankumar Reddy Jalla is a Director at Hitansi Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09659080
Primary Designation Director
Industry Chemicals
First Appointment 30 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hitansi Pharma Private Limited U24290TG2022PTC164341
Director30 Jun 20222022Active

Directorship timeline

Open interactive timeline →
Hitansi Pharma Private Limited
Premium access

Shareholding and investment profile for Pavankumar Reddy Jalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavankumar Reddy Jalla

Pavankumar Reddy Jalla currently holds 1 directorship: Hitansi Pharma Private Limited (Director, since 30 Jun 2022).

Pavankumar Reddy Jalla was first appointed on 30 Jun 2022 as Director at Hitansi Pharma Private Limited.

The current boards of Pavankumar Reddy Jalla's companies include Chaitanya Prakash Marchaya (Hitansi Pharma Private Limited), Nagendra Babu Kutani (Hitansi Pharma Private Limited), Puranjan Reddy Jalla (Hitansi Pharma Private Limited), Reddy Mullangi Satyanarayana (Hitansi Pharma Private Limited), Srinivasa Reddy Kondapally (Hitansi Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available